Meester, M.H.M.

aureus infection patient mupirocin nosocomial aureus infections study carrier aureus bacteraemia hospital aureus infection mortality strain staphylococcus bacteraemia group disease carriage placebo staphylococcus aureus netherland nosocomial infections van keulen center prophylaxi kluytman wertheim point non-carrier percentage difference mupirocin group university admission ointment 0.2 percentage point table trophoblastic analysis trial result verbrugh department application microbiology control hosp epidemiol placebo group amphia hospital culture treatment 0.2 control termination aureus carriers vu university risk difference keulen article incidence signi ficantly center st mupirocin prophylaxis 2 treatment groups -field gel electrophoresis women pulsed-field gel electrophoresis efficacy criteria randomized pregnancy j.a.j.w device centre 1.9 hospitalization p.h.j 5 days mupirocin application h.f.l duration